Active, not recruitingNCT05776225
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
Studying Drug- or toxin-induced pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- United Therapeutics
- Intervention
- Right heart catheterization (RHC)(procedure)
- Enrollment
- 300 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- Pulmonary Associates, Phoenix, Arizona, United States
- Hartford Hospital, Hartford, Connecticut, United States
- Lakeland Regional Health, Lakeland, Florida, United States
- NCH Healthcare System, Naples, Florida, United States
- University of South Florida Health, Tampa, Florida, United States
- Cleveland Clinic Florida, Weston, Florida, United States
- Emory University Hospital, Atlanta, Georgia, United States
- Piedmont Healthcare, Austell, Georgia, United States
- Loyola University Chicago, Chicago, Illinois, United States
- Northwestern University, Chicago, Illinois, United States
- NorthShore University Health System, Glenview, Illinois, United States
- University of Kentucky Medical Center, Lexington, Kentucky, United States
- LSU Health Sciences Center New Orleans, New Orleans, Louisiana, United States
- University of Michigan Int Med Pulmonary and Critical Care, Ann Arbor, Michigan, United States
- Mclaren Greater Lansing, Okemos, Michigan, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05776225 on ClinicalTrials.govOther trials for Drug- or toxin-induced pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07365332An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)Inhibikase Therapeutics
- RECRUITINGNANCT07529821Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive PatientsFoundation University Islamabad
- ACTIVE NOT RECRUITINGNCT07312227A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaMassachusetts General Hospital
- ENROLLING BY INVITATIONNANCT07558460Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialIstanbul University - Cerrahpasa
- RECRUITINGPHASE2NCT07318597Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals
- RECRUITINGNANCT07366879Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial HypertensionGolden Jubilee National Hospital
- RECRUITINGPHASE3NCT07245680COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular ComorbiditiesAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE1NCT06872112A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionJoseph C. Wu
See all trials for Drug- or toxin-induced pulmonary arterial hypertension →